
    
      Patients are randomly assigned to treatment with either candesartan 32 mg/d or Quinapril 20
      mg/d before the angioplasty. Walking distance, intima media thickness and crurobrachial
      pressure ratios are compared after 6 weeks, 3 months and 6 months. After 6 months an
      angiographic control is performed.
    
  